A highly specific phosphatase that acts on ADP-ribose 1″-phosphate, a metabolite of tRNA splicing in Saccharomyces cerevisiae by Shull, Neil P. et al.
AhighlyspecificphosphatasethatactsonADP-ribose
100-phosphate, a metabolite of tRNA splicing in
Saccharomyces cerevisiae
Neil P. Shull, Sherry L. Spinelli and Eric M. Phizicky*
Department of Biochemistry and Biophysics, University of Rochester School of Medicine, 601 Elmwood Avenue,
Rochester, NY 14642, USA
Received December 6, 2004; Revised and Accepted January 7, 2005
ABSTRACT
One molecule of ADP-ribose 100,200-cyclic phosphate
(Appr.p) is formed during each of the approximately
500 000 tRNA splicing events per Saccharomyces
cerevisiae generation. The metabolism of Appr.p
remains poorly defined. A cyclic phosphodiesterase
(Cpd1p) has been shown to convert Appr.pt o
ADP-ribose-100-phosphate (Appr1p). We used a bio-
chemical genomics approach to identify two yeast
phosphatases that can convert Appr1p to ADP-
ribose: the product of ORF YBR022w (now Poa1p),
which is completely unrelated to other known phos-
phatases; and Hal2p, a known 30-phosphatase of
50,30-pAp. Poa1p is highly specific for Appr1p, and
thus likely acts on this molecule in vivo. Poa1 has a
relativelylowKMforAppr1p(2.8mM)andamodestkcat
(1.7min
 1),butnodetectableactivityonseveralother
substrates. Furthermore, Poa1p is strongly inhibited
by ADP-ribose (KI,1 7mM), modestly inhibited by
other nucleotides containing an ADP-ribose moiety
and not inhibited at all by other tested molecules. In
contrast, Hal2p is much more active on pAp than on
Appr1p, and several other tested molecules were
Hal2p substrates or inhibitors. poa1-D mutants have
no obvious growth defect at different temperatures
inrichmedia,and analysisofyeast extractssuggests
that  90% of Appr1p processing activity originates
from Poa1p.
INTRODUCTION
tRNA splicing in Saccharomyces cerevisiae occurs in three
essential steps and produces the by-product adenosine diphos-
phate ribose 100,200-cyclic phosphate (Appr>p). In the ﬁrst step
of splicing, tRNA endonuclease recognizes the pre-tRNA and
removes its intron, leaving a 50 tRNA half-molecule with a
20,30 cyclic phosphate on its 30 end and a 30 half-molecule with
a hydroxyl on its 50 end (1–3). tRNA ligase opens the 20,30
cyclic phosphate to a 20-phosphate, phosphorylates the
hydroxyl on the 30 half-molecule and joins the two half-
molecules to leave a mature length tRNA with a 20-phosphate
at the splice junction (4–6). This 20-phosphate is removed
by tRNA 20-phosphotransferase in two distinguishable steps:
ADP-ribosylation of the 20-phosphate with the cofactor NAD,
followed by resolution of the intermediate to form mature
length spliced tRNA and Appr>p (7–9). Hence, the cyclic
phosphate of Appr>p originates as a backbone phosphate
of the pre-tRNA, and Appr>p is produced in equimolar yield
with spliced tRNA.
Determination of the pathway by which Appr>p is meta-
bolizedisofinterest fortworeasons.First,Appr>pisproduced
in appreciable quantities. Based on the number of tRNA
molecules made per generation (10), and the fraction of tRNA
genes with introns (11,12), it is estimated that  500 000
molecules of tRNA are spliced per generation. In the absence
of a metabolic breakdown pathway, Appr>p could reach a
concentration of 10–40 mM in the cell. Second, Appr>p
could act as a regulatory molecule to signal the status of
tRNA splicing in the cell, since it is produced every time a
tRNA is spliced, and tRNA splicing is likely the only signi-
ﬁcant source of the molecule (8,13). Appr>p may also be
producedduringHAC1mRNAsplicingintheunfoldedprotein
response, since tRNA ligase is involved in the joining step
(14–16), and the resulting 20-phosphate would likely have to
be removed by Tpt1p. However, if so, the amount of Appr>p
produced by HAC1 splicing would be negligible compared
with that produced by tRNA splicing, based on the number of
HAC1 mRNA molecules likely to be made (17,18).
A likely ﬁrst step in Appr>p metabolism in yeast extracts is
the conversion of Appr>p to adenosine diphosphate ribose-100-
phosphate (Appr1p) by Cpd1p (19). A highly speciﬁc cyclic
phosphodiesterase was originally identiﬁed in yeast extracts
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doi:10.1093/nar/gki211(19). Subsequently, this activity was attributed to CPD1
(20,21), Cpd1p was shown to encode cyclic phosphodiesterase
(21), and extracts from cpd1-D yeast strains were shown
to have no detectable CPDase activity (21). These results
suggest that Cpd1p acts on Appr>p in vivo to produce
Appr1p, although there is no evidence that explicitly addresses
this role.
To determine the next step in Appr>p metabolism, we
extended a previous search of a yeast genomic library of
puriﬁed glutathione S-transferase–open reading frame (GST–
ORF) fusion proteins to ﬁnd proteins that act on Appr1p (20).
We report here that ORF YBR022w (now named POA1) and
HAL2 each encode phosphatases that can convert Appr1p to
ADP-ribose in vitro. Poa1p is unusual because it is substan-
tially more speciﬁc and slower than most phosphatases that
act on small molecules; of a number of substrates tested, only
Appr1p is appreciably dephosphorylated by Poa1p. Hal2p
was previously described as a 30-phosphatase acting on
pAp produced during methionine biosynthesis in yeast (22).
Although Hal2p prefers pAp as a substrate to other common
nucleotides (22), Hal2p has appreciable activity on Appr1p
in our in vitro studies. Although either protein could catalyze a
phosphatase reaction after Cpd1p converts Appr>p to Appr1p,
our evidence suggests that Poa1p is responsible for  90% of
Appr1p processing activity in yeast extracts.
MATERIALS AND METHODS
Yeast and Escherichia coli strains, plasmids
and growth
Strains NSY32 (hal2::kan, clone ID#1756) and NSY34
(poa1::kan, clone ID#3159) are derivatives of strain NSY60
(BY4741, MATa, his3-D1, leu2-D0, ura3-D0, met15-D0,
lys2-D0), and were purchased from Open Biosystems. The
kan marker in NSY34 was exchanged for a nat marker by
transformation of EcoRI cut p4339 containing the nat marker
into NSY34 as described previously (23) to form NSY49
(poa1::nat). The poa1, hal2 double mutants were made
by PCR ampliﬁcation of the hal2::kan region of NSY32
with primers 50-GACGCACCAATGTATGGTGCAG-30 and
50-CGATTGCTTTCGAATTTTCAACGGG-30, and trans-
formation of the PCR product into NSY49 to form NSY58
(MATa, hal2::kan, poa1::nat).
Both POA1 and HAL2 were expressed in E.coli as
N-terminal His6-ORF fusion proteins under control of the Plac-
T7 polymerase. POA1 was PCR ampliﬁed from yeast genomic
DNA using primers 50-GAACTCGAGGAATTCATGTCT-
AACATCACTTAT-30 and 50-GAACTCGAGGAATTCT-
TACAGCTGATATACTG-30, XhoI treated, ligated into the
vector pET15b (Novagen) and transformed to create strain
NPS1-14. HAL2 was PCR ampliﬁed from yeast genomic
DNA using primers 50-GAACTCGAGCATATGGCATTG-
GAAAGAGAATTA-30 and 50-GAACTCGAGTTAGGCGT-
TTCTTGACTGAAT-30, treated with NdeI and XhoI, ligated
into pET15b and transformed to create strain NPS51-2.
Plasmids containing sequenced ORFs were transformed into
E.coli BL21(DE3) pLysS cells, grown at 37 C in 500 ml
cultures of Luria–Bertani (LB) containing 100 mg/ml ampi-
cillin to an OD600 = 0.4, induced with 1 mM isopropyl
b-D-thiogalctopyranoside for 30 min at 37 C, harvested,
quick frozen in dry ice and stored at  70 C.
Purification of proteins expressed in E.coli
Puriﬁcation of His6-Poa1p and His6-Hal2p was performed as
described previously (24), using TALON resin (Clontech)
for immobilized metal-ion afﬁnity chromatography (IMAC),
except that puriﬁed proteins were dialyzed into buffer con-
taining 20 mM Tris–HCl, pH 7.5, 4 mM MgCl2, 55 mM NaCl,
1 mM DTT and 50% glycerol.
Preparation of substrates
NAD labeled with
32P on the phosphate adjacent to the aden-
osine (Ap*pN) was prepared based on the method of Culver
et al. (19). An aliquot of 40 mCi [a
32-P]ATP (3000 Ci/mmol,
Amersham Biosciences) and 1 mM NMN (Sigma) were
treated with partially puriﬁed His6-Nma1p (encoding yeast
NMN pyrophosphorylase, prepared from E.coli strain NPS52-
3) in a 20 ml reaction mixture containing 100 mM Tris–HCl,
pH 7.5 and 10 mM MgCl2. Reactions were incubated over-
night at 30 C, and the product Ap*pN was separated from
other reactants on silica TLC plates developed in solvent con-
taining 100% EtOH/1 M NH4OAc, pH 7.2 (7:3 v/v), eluted in
ddH2O and dried to completion.
Ap*pr1p was prepared from Ap*pN, using Tpt1p to convert
labeled NAD to Ap*pr>p and Cpd1p to open the cyclic
phosphate and generate Ap*pr1p. Reaction mixtures of 10 ml
contained 5 · 10
6 c.p.m. Ap*pN, 100 mM unlabeled NAD
(Sigma), 100 mM Tpt1p trimer substrate APA
P
PA and
0.03 mg His6-Tpt1p (derived from strain EMP1199) in buffer
containing 20 mM Tris–HCl, pH 7.5, 5 mM MgCl2, 2.5 mM
spermidine, 100 mM DTT and 0.4% Triton X-100, and were
incubated for60min at30 C.Then, 0.04 mgHis6-Cpd1p (from
strain NPS9-12) was added for 90 min to convert Ap*pr>p
to Ap*pr1p, products were separated on silica TLC plates
developed in solvent containing 1-propanol/NH4OH/
ddH2O(55:35:10, v/v/v), and Ap*pr1p was eluted in water
and ﬁltered with a Spin-X centrifuge tube ﬁlter (Corning
Incorporated).
Unlabeled Appr1p was prepared by a preparative reaction
of chemically synthesized Appr>p [a gift from W. Fillipowicz,
Friedrich-Meiescher-Institute, Basel, Switzerland (25)] with
2 mg His6-Cpd1p under the conditions described above for
4–8 h. Products were isolated on silica TLC plates developed
in solvent containing 100% EtOH/1 M NH4OAc, pH 7.2
(7:5, v/v), excised, eluted in water, ﬁltered and quantiﬁed
based on A260.
Radioactively labeled p*Ap was made from 30 AMP and
polynucleotide kinase as described previously (26), followed
by separation on silica TLC plates developed in solvent
containing 1-propanol/NH4OH/ddH2O (55:35:10, v/v/v).
Unlabeled pAp was purchased from Sigma.
Labeled ribose-1-p* was made by incubation of 10 mM
inosine and 100 mCi [
32P]H3PO4 with 0.75 U nucleoside
phosphorylase (Sigma) in a 10 ml reaction mixture containing
10 mM Tris–HCl, pH 7.5. After 20 min at 37 C, products were
isolated on polyethyleneimine (PEI)–cellulose TLC plates
developed in 0.75 M LiCl. Product spots were excised and
eluted in 0.5 M NH4HCO3, pH 8.0 for 15 min at room tem-
perature, dried to completion and resuspended in water.
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activities
Appr1p phosphatase assays were performed at 30 C in reac-
tion mixtures containing crude extract, GST–ORF fusion
proteins or puriﬁed Poa1p and Hal2p as indicated, in buffer
containing 20 mM Tris–HCl, pH 7.5, 5 mM MgCl2, 2.5 mM
spermidine, 100 mM DTT, 0.4% Triton X-100, 5–25 nM
Ap*pr1p and excess unlabeled Appr1p to adjust substrate
concentration as noted. Reaction products were separated
on PEI–cellulose TLC plates developed with either 1 or 2 M
sodium formate, pH 3.5, and quantiﬁed by PhosphorImager
(MolecularDynamics). Initial rates of Appr1p hydrolysis by
Poa1p (21 nM) or Hal2p (173 nM) were determined in time
courses that led to <15% conversion of substrate to product.
Steady-state kinetic parameters were obtained by ﬁtting the
resulting initial velocities to the Michaelis–Menten equation
using KaleidaGraph software version 3.0. The kinetic para-
meters for pAp phosphatase activity by Hal2p were determ-
ined in an analogous way using trace amounts of labeled p*Ap
with increasing amounts of unlabeled pAp (0–1500 nM).
Hal2p was added at a concentration of 26 fM.
Inhibition reactions
All Appr1p phosphatase inhibition assays were performed in
the presence of 34 nM Poa1p or 104 nM Hal2p, 5 or 5000 nM
Appr1p and 10 mM of potential inhibitor, for a period of
time that converts  50% of substrate to product under non-
inhibited conditions. IC50 values were obtained by titrating
the inhibitor concentration under the same conditions.
KI for ADP-ribose
A KI for ADP-ribose was determined by the method of
Dixon (27).Initial rates of Appr1p hydrolysis were determined
using the previously described Ap*pr1p assay, with 43 nM
Poa1p and varied concentrations of Appr1p (1–25 mM) and
ADP-ribose (0–300 mM). The inverse of the initial rates
determined at each different ﬁxed concentration of substrate
was plotted as a function of[ADP-ribose].The resulting slopes
are linearly dependent on 1/[Appr1p]; the KI for ADP-ribose
was determined from the slope of this second plot since
slope = KM/(VmaxKI), and KM and Vmax are known for
Appr1p. All ﬁts were performed by linear regression with
KaleidaGraph software.
Determination of pH maximum for Poa1p
Time-course reactions were performed in reaction mixtures
containing 25 nM Ap*pr1p and 5 nM Poa1p in buffer con-
taining 5 mM MgCl2, 2.5 mM spermidine, 100 mM DTT and
0.4% Triton X-100, as well as 20 mM of one of the following
buffers:NaOAc,pH4.0,4.5,4.7and5.0;Homo-PIPES,pH4.7
and 5.0; MES, pH 5.4, 5.8, 6.0 and 6.2; Bis-Tris, pH 6.0,
6.6 and 7.0; HEPES, pH 7.0 and 7.5; and Tris–HCl, pH 7.5 and
8.0. Several time-course reactions were performed at the same
pH in two separate buffers to rule out buffer speciﬁc effects.
RateswereplottedandpKaswereﬁttothecurveusingKaleida-
Graph software using the equation ðv=EÞobs ¼½ ð v=EÞlow pH þ
ðv=EÞmax10ðpH pKa1Þ =½1 þ 10ðpH pKa1Þ þ 10ðpKa2 pHÞ :
Test of other substrates at pH 6.0
Potential substrates of Poa1p were assayed at pH 6.0 by
incubation of 5.3 mM Poa1p (or an equivalent amount of
a mock puriﬁcation) with test substrates for 16–24 h at 30 C.
Ribose-1-p* was tested at 10 nM or 3 mM, and phosphate
product was resolved from reactant on PEI–cellulose TLC
plates developed in 1 M sodium formate, pH 3.5. All other
substrates were tested at 1 mM, and phosphate product was
measured using a malachite green assay (28).
Assay of yeast crude extracts
Yeast crude extracts were made as described with glass beads
(29) from cells that were grown to A600 of 1.0, harvested,
washed in cold ddH2O and stored at  70 C, and then assayed
for Ap*pr1p processing activity for 1 h at 30 C with 17 nM
Ap*pr1p, and 5-fold serial dilutions of extract, starting with
16 mg wild-type extract, 29 mg poa1::nat extract, 23 mg hal2::
kan extract or 21 mg poa1::nat, hal2::kan extract.
RESULTS
Identification of two phosphatases with activity
on Appr1p
A previous survey of a genomic collection of puriﬁed
S.cerevisiae GST–ORF fusion proteins indicated that ORF
YBR022w co-puriﬁes with an Appr1p processing activity
(20). This collection is derived from a library of 6144 yeast
strains, each expressing a unique GST–ORF fusion protein
(30). Assignment of Appr1p processing activity to this ORF
involvedpuriﬁcation of64 pools of GST–ORFfusion proteins,
each derived from 96 strains, assays of the pools and decon-
volution of the active pool 6 to show that ORF YBR022w is
associated with the activity.
Another screen of this same library, using Appr1p labeled
with
32P on the phosphate adjacent to the adenosine (denoted
Ap*pr1p, see Materials and Methods), and longer incubation
times for increased sensitivity, revealed pool 6, as expected,
as well as pool 49, as having apparently identical activity
on Appr1p (Figure 1A). In each case, it appears that three
products are formed during the reaction, labeled I, II and III.
Deconvolution of pool 49 (Figure 1B) shows that Appr1p
processing activity co-puriﬁes with the previously described
pAp phosphatase, Hal2p (Met22p).
The products of ORF YBR022w and Hal2p could each have
catalytic activity, could each be associated with separate
activities or could both be part of the same complex. To
examine the activity of the proteins separately from other
yeast components, each protein was expressed in E.coli and
puriﬁed. As shown in Figure 2A, crude extracts from cells
expressing each protein produce a prominent polypeptide of
the expected size (27 kDa for the product of ORF YBR022w
and45kDaforHal2p)thatisabsentincontrolextracts(cf.lanes
a and b and lanes e and f). Each protein was then puriﬁed by
immobilized metal-ion chromatography (see Materials and
Methods), resulting in substantially puriﬁed preparations,
as determined by SDS–PAGE analysis (Figure 2A, lanes c,
d,gandh).ExaminationofAppr1pprocessingactivitydemon-
strates that YBR022w protein and Hal2p have similar activit-
ies, each producing substantial amounts of products I and II,
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(see Figure 2B, lanes c–g and lanes h–l).
Since Hal2p is a known phosphatase acting on the 30-phos-
phate of pAp, it seems likely that both YBR022w protein and
Hal2p are phosphatases acting on the 100-phosphate of Appr1p,
although the appearance of two products from each protein
was unexpected. To further characterize the products observed
upon reaction with these proteins, we compared the activities
of YBR022w protein and Hal2p with that of calf intestinal
phosphatase (CIP). As shown in Figure 2B, incubation
of Appr1p with CIP yields the same characteristic two
products I and II as YBR022w protein and Hal2p, both of
which co-migrate with ADP-ribose from a commercially
obtained standard (cf. lanes c–g and h–l with lanes m–q).
We have conﬁrmed that CIP and YBR022w protein produce
the same products from Appr1p with several other TLC
systems, although in most of these systems ADP-ribose
migrates as a single spot (data not shown). This result demon-
strates that YBR022w protein and Hal2p are phosphatases that
remove the 100-phosphate from Appr1p, and therefore we
assigned the name POA1 to ORF YBR022w (phosphatase
of ADP-ribose 100-p).
A kinetic characterization of Poa1p and Hal2p reveals
differing catalytic efficiencies for Appr1p
To evaluate the possible contribution of each protein to
Appr1p metabolism, we compared the steady-state kinetic
parameters of Poa1p and Hal2p with Appr1p and with pAp,
the previously known substrate of Hal2p. We used labeled
Appr1p and pAp to monitor phosphatase activity and meas-
ured the reaction progress as a function of increasing concen-
tration of either substrate. Both spots that have been identiﬁed
as ADP-ribose (I and II) were summed to equal the total
amount of products in each reaction and all reactions were
linear over the time measured. Some representative time
courses for the hydrolysis of Appr1p with Poa1p are shown
in Figure 3A. The resulting initial rates were plotted as a
function of substrate concentration and were ﬁt to the
Michaelis–Menten equation to yield the steady-state kcat and
KM for each enzyme and substrate combination (Figure 3B;
data not shown). The data were well described by this equation
and are summarized in Table 1.
The results of the kinetic characterizations indicate that
Poa1p is a more efﬁcient enzyme for hydrolysis of Appr1p
than Hal2p, although both act relatively slowly on this
Figure 1. Identification of two yeast ORFs associated with activity on Appr1p. (A) Assay of a genomic collection of pools of purified yeast GST–ORF fusion
proteins. Pools of GST–ORF fusion proteins were assayed for Appr1p processing activity at 30 C for 4 h with 40 nM Ap*pr1p and products were resolved on PEI–
celluloseTLCplatesdevelopedin1Msodiumformate.a,buffercontrol.ProductsI,IIandIIIareindicated.(B)Assayofsub-poolsofplate49foractivityonAppr1p.
Sub-pools of GST–ORF fusion proteins from rows A–H and columns 1–12 of plate 49 were assayed with 3 nM Ap*pr1p at 30 C for 1 h, as indicated, and resolved
as in (A). a, GST–ORF pool of plate 49.
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kcat values (Poa1p, kcat = 1.7 min
 1, Hal2p, kcat = 3.2 min
 1),
but Poa1p has an  25-fold lower KM (Poa1p, KM = 2.8 mM,
Hal2p, KM = 74 mM), resulting in a kcat/KM difference of
14-fold in favor of Poa1p. Thus, this data suggest that either
enzyme could work on Appr1p in vivo in yeast.
Hal2p greatly prefers its known substrate pAp, whereas
Poa1p appears to not recognize this substrate. Consistent
with previously published values (26,31), we ﬁnd that
Hal2p has a much lower KM (0.1 mM) and a much higher
kcat (54 min
 1) for pAp than is observed for Appr1p. In
contrast, Poa1p has no detectable activity on pAp, under
conditions where a turnover of 0.005 min
 1 (0.3% of the
activity with Appr1p) should be easily observed (data not
shown). Thus, Hal2p prefers the substrate pAp by 10
4-fold
relative to Appr1p, as measured by kcat/KM values, whereas
Poa1p prefers Appr1p at least 340-fold relative to pAp, as
measured by observed rates.
A number of experiments conﬁrmed that the slow rate of
Appr1p hydrolysis by Poa1p was likely not an artifact.
First, we showed that the position or the presence of the
puriﬁcation tag did not affect the activity. Titration experi-
ments of puriﬁed proteins demonstrate that Poa1p with an
N-terminal His6 tag is equally as active as Poa1p with a
Figure 2. Overexpression and purification of Poa1p and Hal2p from E.coli.( A) His6-YBR022w protein and Hal2p were purified as described in Materials and
MethodsfromextractsofstrainsexpressingHis6-YBR022wprotein(a–d)andHis6-Hal2p(e–h),andanalyzedbySDS–PAGE.aande,40mgcrudeextractfromstrain
expressingvector;bandf,40mgcrudeextractfromstrainexpressingHis6-YBR022wprotein(b)orHis6-Hal2p(f);c,d,gandh,5and8mgpurifiedHis6-YBR022w
protein (c and d) or His6-Hal2p (g and h). (B) His6-YBR022w protein, Hal2p and CIP all act as a phosphatase on Appr1p. Reactions mixtures containing 19 nM
Ap*pr1psubstrateand210nMpurifiedHis6-YBR022wprotein,520nMpurifiedHal2por56fMCIPwereincubatedat30 C,andreactionswerestoppedbyspotting
2 ml to PEI–celluloseplatesthat werethenresolvedasin Figure1. a and b,buffer controlfor0 and 60min;c–l, reactionscontainingYBR022wprotein(c–g),Hal2p
(h–l), or CIP (m–q) incubated for 0, 15, 30, 45 and 60 min. Migration of AMP (pA), ADP-ribose (Appr), and products I, II and III are indicated.
654 Nucleic Acids Research, 2005, Vol. 33, No. 2C-terminal His6 tag, and titrations of extracts demonstrate that
the His6-Poa1p has the same activity as Poa1p with a different
N-terminal tag, or Poa1p with no tag at all (data not shown).
Second, the activity of Poa1p is not stimulated by altering
salt concentrations. Indeed, as the salt was raised from 4 to
104 mM, the rate of hydrolysis was reduced by 21% under
kcat conditions, and by 72% under kcat/KM conditions.
Third, the activity of Poa1p was not signiﬁcantly affected
by pH under kcat/KM or kcat conditions. We determined the rate
of hydrolysis of Appr1p by Poa1p at different pH values ran-
ging from pH 4.0 to pH 8.0, using a concentration of Appr1p
well below the KM under standard conditions (25 nM). As
shown in Figure 4, a bell-shaped curve is observed under
kcat/KM conditions, with pKa values at pH 5.0 and pH 7.0,
and a maximum at  pH 6.0. However, the rate of hydrolysis at
pH 6.0 is only  3.5-fold greater than that at pH 7.5. Experi-
ments with different buffers at several pH values ensure that
these differences are not due to buffer effects. A similar small
difference was observed under kcat conditions. At Appr1p
concentrations of 40 mM, well above the KM at pH 7.5, the
observed rate of Appr1p hydrolysis varied only  2-fold as the
pH was varied from 7.5 to 6.2 (data not shown). Thus, Poa1p
phosphatase activity is not affected signiﬁcantly at either
high or low concentrations of Appr1p within this pH range.
Poa1p is highly specific for Appr1p
Although Poa1p is a relatively slow phosphatase when acting
on Appr1p, it appears to be highly speciﬁc for this substrate.
We examined a number of other small molecules as possible
substrates for Poa1p, but did not ﬁnd any other molecule that
was subject to Poa1p-catalyzed dephosphorylation. Ribose-
1-p was a likely candidate, because Poa1p removes the
100 phosphate from the ribose moiety of Appr1p; however,
no signiﬁcant activity (<5 · 10
 5 min
 1) was found from
an overnight incubation of 5.3 mM Poa1p with ribose-1-p*,
when assayed at both low and high concentrations of the
substrate. Similarly, Poa1p had no detectable activity above
background(<0.004–0.01min
 1)with1mMconcentrationsof
other potential substrates, including pAp, NADP, ribose-5-p,
Figure 4. The pH activity profile for Poa1p under kcat/KM conditions. Poa1p
Appr1pphosphataseactivitywasmeasuredat30 Cwith5nMPoa1pand25nM
Ap*pr1p at different pH values over a suitable time course, and rates were
determined,asdescribedinMaterialsandMethods.Thefollowingbufferswere
used: NaOAc, pH 4.0, 4.5, 4.7 and 5.0; Homo-PIPES, pH 4.7 and 5.0; MES,
pH 5.4, 5.8, 6.0 and 6.2; Bis-Tris, pH 6.0, 6.6 and 7.0; HEPES, pH 7.0 and 7.5;
and Tris–HCl, pH 7.5 and 8.0.
Table 1. Kinetic parameters for Poa1p with Appr1p, and Hal2p with Appr1p
and pAp
Enzyme Substrate KM (mM) kcat (min
 1) kcat/KM (M
 1 s
 1)
Poa1p Appr1p 2.8 1.7 1.0 · 10
4
Hal2p Appr1p 74.0 3.2 7.2 · 10
2
Hal2p pAp 0.1 54.0 1.0 · 10
7
Figure 3. Kinetic parameters of Poa1p phosphatase for Appr1p. (A) Time
courses of conversion of Appr1p to ADP-ribose at different substrate concen-
trations. Appr1p phosphatase activity was measured at 30 C for the times
indicated, in reaction mixtures containing 21 nM Poa1p, 5–25 nM labeled
Ap*pr1p and unlabeled Appr1p. Products were resolved as in Figure 2 and
quantified, and data were plotted using KaleidaGraph software. (B)A
Michaelis–Menten plot of the Appr1p phosphatase activity of Poa1p. Data
from (A) were fit to a Michaelis–Menten curve using KaleidaGraph software.
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p, Ap, A
p, pA, U
p,C
p and 5020 pAp using
a sensitive colorimetric assay (see Materials and Methods),
and assays at either the optimum pH or in many cases also
at pH 7.5. In contrast, CIP exhibited phosphatase activity on
all of the substrates.
Poa1p specifically recognizes the ADP-ribose moiety
Of a number of molecules examined as potential inhibitors
of Poa1p, only those with an ADP-ribose moiety have any
signiﬁcant effect. We surveyed the effect of 10 mM concen-
trations of various nucleotides and sugar phosphates on the
activity of Poa1p measured at Appr1p concentrations well
below KM (26 nM), or at 1.8 KM (5 mM), and then determined
IC50 values of those that inhibited. Poa1p phosphatase activity
was strongly inhibited by ADP-ribose (IC50,3 0mM), moder-
ately inhibited by other molecules that contained an ADP-
ribosemoiety(AppA,NADandNADP,withIC50valuesinthe
range 1–2 mM), marginally inhibited by ADP, Ap and C
p
(with IC50 values > 10 mM) and not inhibited at all by any
othertestednucleotideorsugarphosphate(Table2).Thisresult
underscores the suggestion that Poa1p is speciﬁc for Appr1p,
and suggests further that recognition involves the ADP-ribose
moiety. In contrast, Appr1p phosphatase activity of Hal2p
(monitored at concentrations of Appr1p well below KM)i s
inhibited by a variety of molecules including ADP-ribose,
NADP, Ap, pAp, G
p and ribose 5-phosphate, as might be
expected of a phosphatase with several substrates (data not
shown).
To determine the mode of inhibition of ADP-ribose, the
strongest of the Poa1p inhibitors, initial rates were determined
at varied concentrations of both Appr1p (0.031–25 mM) and
ADP-ribose (0–300 mM). The resulting inverse initial rates
for each substrate concentration were plotted as a function of
inhibitor concentration (Figure 5A), yielding plots with slopes
that vary as a function of [S], and converge on the same
y-intercept, indicative of classical competitive inhibition.
A Dixon plot of the resulting slopes for each line versus
1/[Appr1p] yields the KI,ADP-ribose of 17 mM (Figure 5B).
Therefore, Poa1p is strongly inhibited by the product of its
own reaction.
Extracts of poa1-D mutants have little activity on
Appr1p in vitro
Examination of Appr1p processing in yeast extracts suggests
that Poa1p is responsible for most of the observed Appr1p
phosphatase activity. We compared the activity of crude
extracts from a wild-type control haploid strain with those
from poa1-D mutants, hal2-D mutants and poa1-D, hal2-D
double mutants (see Materials and Methods). As shown in
Figure 6, high concentrations of a wild-type extract (lane a)
produce predominantly Pi, whereas lower concentrations
(lanes b and c) produce primarily AMP. Presumably, ADP-
ribose is formed initially, and then rapidly cleaved by a
Table 2. Inhibitors of Appr1p phosphatase activity of Poa1p
a
Competitor IC50
ADPR 30 mM
AppA 1 mM
NAD 1.5 mM
NADP 2 mM
ADP >10 mM
30pA >10 mM
20pC >10 mM
5030pAp ND
b
50pA ND
20pA ND
20pG ND
30pG ND
30pC ND
ribose-1p ND
ribose-5p ND
glucose-1p ND
fructose-6p ND
glyceraldehyde-3p ND
aForsurveysat10mMcompetitor,8nMPoa1p,26nMAppr1p,1h;and35nM
Poa1p, 5 mM Appr1p, 2 h; for IC50 values, 35 nM Poa1p, 5 mM Appr1p, 2 h.
bND, no detected inhibition in survey at 10 mM.
Figure 5. Determination of KI of ADP-ribose for Poa1p. (A) Plot of 1/v versus
[ADP-ribose] for each of four Appr1pconcentrations. Poa1p Appr1pphospha-
taseactivitywasmeasuredattheindicatedconcentrationsofAppr1pandADP-
ribose for a suitable time course as described in Figure 3, and rates were
determinedandplottedasindicated.(B)Plotofslopeversus1/[Appr1p].Slopes
were obtained for each curve in (A) above, and plotted versus 1/[Appr1p] as
indicated. The slope of this plot (KM/Vmax KI) was used to determine the KI
of ADP-ribose (17 mM), as described in Materials and Methods.
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by another phosphatase to yield Pi. Although ADP-ribose
co-migrates with AMP in the TLC shown in Figure 6, resolu-
tion of the products in a different TLC system demonstrates
that little ADP-ribose is evident in the products (data not
shown). Quantiﬁcation of the titrations shows that Appr1p
is 50% processed by 1.8 mg wild-type extract, 1.2 mg hal2-
D extract, 33 mg poa1-D extract or 20 mg poa1-D, hal2-D
double mutant extract. Thus, in crude extracts under these
conditions, Poa1p is responsible for  90% of the phosphatase
activity on Appr1p, while Hal2p has little detectable activity
on this molecule. The phosphatase activity that is remaining in
a poa1-D extract is likely due to one or more non-speciﬁc
phosphatases, sinceitisinhibitedbyGp,anunrelatedsubstrate
(data not shown).
Poa1p has no significant homologies by blast search
Comparison of the sequence of Poa1p with other proteins in
available databases reveals little sequence homology to other
proteins as determined by BLAST (32) and, in particular, no
homology to any known phosphatase. Poa1p is a member of
a family that is highly conserved in Candida glabrata (e
 53)
and Candida albicans (e
 22), as well as four other fungal
species (e
 20 to e
 6), but only poorly conserved in other
organisms. The best other BLAST score is 1 · 10
 5, with
an Enterobacteria phage RB69 sequence for a homologous
protein of unknown function (accession nos AAP76015.1
andGI:32350416).Theroleofthesehomologsintheirrespect-
ive organisms is unknown. The entire Poa1p sequence has also
been deﬁned as a domain in the SMART database (http://
smart.embl.-heidelberg.de/smart/do_annotation.pl?DOMAIN=
A1pp). This domain, A1pp, occurs in 301 proteins from
organisms in all three major kingdoms. Notably, the A1pp
domain occurs three times in human poly(ADP-ribose) poly-
merase 14, in the C-terminal region of the macro-
histone H2A family, and in the non-structural proteins of
some single-stranded RNA viruses. We note that Poa1p does
not appear in any of the physical interaction, genetic interac-
tion or localization data sets, as summarized at the Saccharo-
myces Genome Database (http://www.yeastgenome.org/);
thus, there is no additional information about its function.
Figure 6. ComparisonofAppr1pprocessingactivityofcrudeextractsfromwild-typecellsandcellslackingPoa1pand/orHal2p.Crudeextractsderivedfromwild-
type cells and poa1-D mutant, hal2-D mutant, or poa1-D, hal2-D double mutant cells were serially diluted 5-fold and assayed for Appr1p processing activity with
17 nM Ap*pr1p for 1 h at 30 C, as described in Materials and Methods. a–e, 16–0.04 mg wild-type extract; g–k, 23–0.04 mg hal2-D extract; l–p, 29 mg to 0.05 mg
poa1-Dextract;r–v,21–0.03mgpoa1-D,hal2-Dextract;fandq,buffercontrols.Reactionsweretreatedwithphenol:chloroformandresolvedbyTLCasinFigure1.
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We have identiﬁed two phosphatases that can act on Appr1p,
a probable downstream product of the tRNA splicing pathway
in S.cerevisiae, to produce ADP-ribose: Poa1p, a previously
undescribed protein; and Hal2p, a known phosphatase that acts
on pAp produced during methionine biosynthesis (22). The
kinetic data suggest that either enzyme could act on Appr1p
in vivo. Although Poa1p has a kcat/KM for Appr1p that is  14-
fold higher than that of Hal2p for this molecule (1.0 · 10
4
versus 7.2 · 10
2), this preference is partially offset by the
6.3-fold increased cellular concentration of Hal2p relative to
Poa1p (7330 versus 1170 molecules) (33).
Two lines of evidence suggest that Poa1p is responsible for
Appr1p phosphatase activity in the cell. First, Poa1p is highly
speciﬁc for Appr1p. A survey of a number of small molecules
yielded no other potential substrate of Poa1p, under conditions
where 0.3% of the activity observed with Appr1p could be
detected. Furthermore, among a variety of molecules tested,
signiﬁcant inhibition of Poa1p activity is only observed from
dinucleoside pyrophosphates bearing an ADP-ribose moiety
(Table 2 and Figure 5), suggesting that this moiety is a major
determinant of speciﬁcity. In contrast, Hal2p is a much less
speciﬁc phosphatase for Appr1p; indeed, Hal2p is known to
remove the 30-phosphate of pAp and the 20-phosphate of cer-
tain nucleotides (22), in addition to its activity described here
on the phosphate at the 1 position of ribose. Second,  90%
of the activity observed in cell extracts appears to be due to
Poa1p, as determined by the analysis of extracts from mutant
cells (Figure 6). Furthermore, the remainder is likely due to a
phosphatase other than Hal2p, based on the lack of observed
difference in Appr1p phosphatase activity between wild-type
and hal2-D extracts, and between poa1-D and poa1-D, hal2-D
extracts; this minor phosphatase was not observed in our
genomic survey, perhaps because the proteome examined
is not complete (34). Thus, our results suggest that Poa1p
acts on Appr1p in the cell.
Poa1p is an unusual phosphatase in two respects. First,
it lacks homology with any other phosphatase. Other known
small molecule phosphatases in yeast are members of a
yeast phosphatase family or have close orthologs in other
organisms (BLAST scores of e
 30 or less). For example,
among yeast phosphatases Pho3p, Pho5p, Pho11p, Pho12p
and Dia3p form a highly homologous family, with >75%
identity among them, and Dog1p, Dog2p, Gpp1p and
Gpp2p align with >35% identity. Similarly, two other yeast
phosphatases, His2p and Ser2p, are highly conserved phos-
phatases from species to species, with roles in amino acid
biosynthesis, and Hal2p shares a conserved domain with
fructose 1,6 bisphosphatase according to the cDART database
(http://www.ncbi.nlm.nih.gov/Structure/lexington/lexington.
cgi). In contrast, Poa1p is not closely related to any known
phosphatasebythesesearchmethods.Theonlyconnectiontoa
protein of known function is the presence of the A1pp domain
of Poa1p in poly(ADP-ribose) polymerase 14 and in the
macro-histone H2A family, as deﬁned by the SMART data-
base. This A1pp domain in other proteins may have a similar
phosphatase activity or a similar ADP-ribose binding activity
to that of Poa1p.
Second, Poa1p is highly speciﬁc for its substrate Appr1p.
A large number of acid and alkali phosphatases found in E.coli
and eukaryotes remove phosphates from a wide range of small
molecules (35–39);indeed,even metabolicphosphatases, such
as glucose-6-phosphatase, have signiﬁcant activity on several
other substrates (40). In contrast, the high speciﬁcity of Poa1p
for its substrate Appr1p is much more similar to the high
speciﬁcity of regulatory phosphatases, such as fructose 2,6
bisphosphatase (41).
The results described here illuminate the likely last steps
of a unique metabolic pathway, in which Appr>p is formed
during tRNA splicing and then broken down to more common
metabolites after splicing. Formation requires the sequential
action of tRNA ligase to generate ligated tRNA with a splice
junction 20-phosphate, and Tpt1p to transfer the phosphate to
NADto form Appr>p. Breakdown of Appr>pis likelyinitiated
by Cpd1p, generating Appr1p (19–21,42). This is inferred
from the lack of Appr>p cyclic phosphodiesterase activity
in extracts lacking Cpd1p (21), and the speciﬁcity of Cpd1p
for Appr>p (19) (N. P. Shull and E. M. Phizicky, unpublished
data), although others have found that Cpd1p is only modestly
speciﬁc for Appr>p (21). Then, based on the results described
here, Appr1p is processed by Poa1p, and possibly another
minor phosphatase, to generate ADP-ribose. Finally, it seems
likely that a pyrophosphatase converts ADP-ribose to AMP,
based on the observed production of pA and subsequently Pi
in extracts. Since poa1-D extracts lack most of the Appr1p
phosphatase activity, and produce much less pA and Pi than
wild-type extracts, we conclude that the pyrophosphatase acts
primarily on ADP-ribose and not on Appr1p.
The recent remarkable ﬁndings of Schwer et al. (43) dem-
onstrate that the otherwise essential ligase/phosphotransferase
pathway of tRNA splicing (5,13,44) can be replaced by T4
enzymes that ligate tRNAs without producing splice junction
20-phosphates or Appr>p, and that cells expressing the corres-
ponding T4 genes have no obvious growth defect. We specu-
lated previously that Appr>p might have a regulatory role
because it is formed in equimolar yield during tRNA splicing
(8,13). Although the results of Schwer et al. (43) suggest that
the production of Appr>p is not essential, the accumulation
of Appr>p could have cellular consequences.
We note that the cellular population of Poa1p is not quite
enough to clear all of the Appr1p generated by tRNA splicing
and the subsequent action of Cpd1p, based on our estimate of
500 000 tRNAs spliced per generation, the concentration of
Poa1p in the cell (33) and the kinetic parameters of Poa1p.
Experiments described above establish that the low hydrolysis
rate of Poa1p is not due to factors, such as salt concentration,
pH or the presence of the puriﬁcation tag on the protein.
Rather, the slow turnover might be inherent to the protein,
perhaps due to the slow release of ADP-ribose. Thus, there
may be a basal concentration of Appr1p in the cell, unless
Poa1pisstimulatedbyothercellular factors,orthereisanother
source of Appr1p processing activity. We note that Cpd1p
does not stimulate or inhibit Poa1p under kcat/KM or kcat con-
ditions. It is possible that the slow turnover of Poa1p is tol-
erated due to the low metabolic demand forAppr1p processing
and the lack of physiological consequence of Appr1p in the
cell. In this connection, we note that poa1-D mutants, which
might be expected to accumulate Appr1p, have no obvious
growth phenotype in rich media at different temperatures, and
that poa1-D hal2-D double mutants do not have any noticeable
growth defect relative to single mutants. Alternatively, it is
658 Nucleic Acids Research, 2005, Vol. 33, No. 2conceivable that the speculated regulatory role of Appr>p (8)
is exerted through Appr1p, since it is uniquely generated
through the same pathway that produces Appr>p.
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